Anat Globerson Levin, n/a

Head of Immunology and Advanced CAR-T based cell therapy laboratory
Tel-Aviv Sourasky Medical Center, Israel

Presentation(s):

• 52: Anti-HER-2 Chimeric Antigen Receptor T (CAR-T) Cells Immunotherapy for Pancreatic Cancer: An Innovative Surgically Derived Tumor Spheroid Model

  Saturday, March 23, 2024
  8:22am – 8:32am ET